Stock Analysis of Tricida Inc (TCDA) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code TCDA
Close 0.0141
Change 0.0011 / 8.46 %
Volume 152020
Vol Change -54765.00 / 26.48 %
IndustryBiotechnology & Medical Research
SectorHealthcare
AIO Strength Index
Technical StrengthMild Bearish
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Poor Stability Stock


Fundamental View of Tricida Inc
PE (TTM)

-0.0060

Very Poor
Price / Book

-0.0120

Very Poor
Price / Sales

0

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

818199

Enterprise Value

109953 K

ROA (TTM)

-98.22

Very Poor
ROE (TTM)

0

Poor
Net Margin (TTM)

0

Poor
Revenue

%

0
Net Profit

33.32 %

-176566.00 K
Debt to Equity

597.47

Very Poor
Altman Z Score

-9.02

Very Poor
Quick Ratio

0

Poor
Cash Ratio

4.77

Very Good


Highs/Lows of Tricida Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.0126 11.90 % 0.513 % 0.0150.012624-Mar-2321-Mar-23
Two Week0.013 8.46 % 0.486 % 0.0150.012624-Mar-2321-Mar-23
One Month0.0181 22.10 % 4.80 % 0.01810.01228-Feb-2307-Mar-23
Three Month0.137 89.71 % 3.56 % 0.2590.01212-Jan-2307-Mar-23
Six Months9.51 99.85 % 15.54 % 13.1190.01212-Oct-2207-Mar-23
One year8.46 99.83 % 26.26 % 13.850.01224-Aug-2207-Mar-23
Two year5.14 99.73 % 27.72 % 13.850.01224-Aug-2207-Mar-23


Technical View of Tricida Inc
RSI

29.14

Mild Bullish
MACD

-0.0114

Strong Bullish
ADX

36.04

Mild Bearish
Super Trend

0.0224

Mild Bearish
Williams %R

-53.33

Neutral
CCI

-32.60

Neutral


EMA 5

0.0134

Strong Bullish
EMA 15

0.0148

Mild Bearish
EMA 50

0.214

Mild Bearish
EMA 100

1.39

Mild Bearish
SMA 100

0.129

Mild Bearish
SMA 200

5.24

Strong Bearish
SMA 5 / 20

0.0131 / 0.0139

Mild Bearish
SMA 15 / 50

0.0136 / 0.0406

Mild Bearish
SMA 50 / 200

0.0406 / 5.24

Strong Bearish




Charts of Tricida Inc


Returns of Tricida Inc with Peers
Period / StockTCDASRNEBBIGLSACOR
1 Week11.90%-12.43%-1.07%-92.41%-60.65%
1 Mth-22.10%2.86%-0.892%-94.73%-94.49%
3 Mth-89.71%-71.33%-8.13%-96.62%-95.96%
6mth-99.85%-78.11%-9.06%-98.75%-93.85%
1 Year-99.83%-84.04%41.80%-99.76%-93.99%
2 Year-99.73%-95.32%-94.82%-99.88%-98.01%
5 Years--94.46%-99.75%--99.96%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Tricida Inc with Peers
Ratio / StockTCDASRNEBBIGLSACOR
PE-0.0060-0.227-0.00160.0171-0.0017
P/B-0.01201.190.0024-0.163-0.0346
ROA-98.22-113.01-122.1778.34-170.31
ROE0-990.86-151.0300
Debt To Equity597.47-1.900.0028-1013.84-0.0101
Revenue0
% 		62839.00 K
18.78 % 		404000
77.83 % 		25767.00 K
130.37 % 		111118 K
6.28 %
Net Income-176566.00 K
33.32 % 		-572843.00 K
33.74 % 		-39474.00 K
88.75 % 		-95062.00 K
1.84 % 		-15951.00 K
75.80 %


Technicals of Tricida Inc with Peers
Technical / StockTCDASRNEBBIGLSACOR-
ADX36.0412.4411.9815.1739.16
CMF-0.1830.0114-0.272-0.194-0.438
MFI59.7252.3627.0533.160.925
RSI29.1441.0548.2525.9117.04
MACD Abv SignalTrueTrueTrueFalseFalse
Price Above 50 MAFalseFalseFalseFalseFalse-
Price Above 200 MAFalseFalseTrueFalseFalse-


About : Tricida Inc

Address : 7000 Shoreline Court, South San Francisco, CA, United States, 94080
Tel : 415 429 7800
URL : https://www.tricida.com
Code : TCDA, ISIN : US89610F1012, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 28_Jun_2018
Employee Count : 57

Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California. On January 11, 2023, Tricida, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.


Note : All Data Generated at the End of Trading Hours (EOD Data)